Venous thromboembolism risk assessment tools: Do we need a consensus?
نویسندگان
چکیده
منابع مشابه
Ramadan fasting: Do we need more evidence?
Over a billion of Muslims fast worldwide during Ramadan each year. Through this religious custom, fasting contributes to their health as well as their spiritual growth. However, available evidence regarding the health-benefits of Ramadan fasting is scarce and highly contentious. Although Islam exempts patients from fasting, many fast conceivably, and their clinical condition is prone to deterio...
متن کاملStaff Burnout… Do we need any intervention?
Dear Editor, As you know physical and mental wellness of physicians and nurses, as the main role in the treatment of patients, in conditions such as burnout, compassion fatigue, depression, and poor work-life balance, is one of the top priorities in the U.S.A. National Academy of Medicine (1-4). Although healthcare team members are generally known as a caregiver to others; their h...
متن کاملDo We Need 'Agile' Software Development Tools?
Lightweight, 'agile' software development methods are not a replacement for traditional, heavyweight methods. But under certain assumptions, they are a welcome alternative in many areas of software development. In this paper, we outline the di erences between agile and traditional approaches of software development and examine how development tools are used in the latter. We consider experience...
متن کاملDDH Epidemiology Revisited: Do We Need New Strategies?
Background: Although the developmental dysplasia of the hip (DDH) is well known to pediatric orthopedists, its etiology has still remained unknown and despite dedication of a vast majority of research, the results are still inadequate and confusing. The exact incidence of DDH and its relationship with known risk factors in Iran is still unknown. Here we represent the results of one year study o...
متن کاملMultilocus Genetic Risk Scores for Venous Thromboembolism Risk Assessment
BACKGROUND Genetics plays an important role in venous thromboembolism (VTE). Factor V Leiden (FVL or rs6025) and prothrombin gene G20210A (PT or rs1799963) are the genetic variants currently tested for VTE risk assessment. We hypothesized that primary VTE risk assessment can be improved by using genetic risk scores with more genetic markers than just FVL-rs6025 and prothrombin gene PT-rs1799963...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Phlebology: The Journal of Venous Disease
سال: 2019
ISSN: 0268-3555,1758-1125
DOI: 10.1177/0268355519828863